Latest Competition News

Auswide Bank Ltd's shares have been suspended from trading following court approval of its acquisition by MyState Bank Limited, marking a significant consolidation in the Australian retail banking sector.

Dicker Data Limited has announced a fully franked ordinary dividend of AUD 0.11 per share for the quarter ending December 2024, alongside a Dividend Reinvestment Plan offering shareholders flexibility.

Merchant House International Limited has sold equipment from its shuttered American Merchant Inc textile factory for US$4 million, crystallising a significant A$9.02 million loss. The company continues to seek buyers for the remaining land and buildings.

Gyder Surgical, backed by Hydrix Ventures, has secured FDA 510(k) clearance for its innovative GYDER Hip System, opening the door to the lucrative U.S. market and increasing Hydrix’s investment value.

TEAMINVEST PRIVATE GROUP LIMITED has announced a fully franked ordinary dividend of AUD 0.015 per share for the six months ending December 31, 2024, payable in March 2025.

Auswide Bank’s acquisition by MyState Bank has reached a key milestone with the scheme of arrangement now legally effective, triggering a suspension of Auswide’s shares and setting the stage for shareholder transitions.

Bass Oil Limited is set to deepen its exploration of the Triassic gas play in the northern Cooper Basin following a successful flow test at the Kiwi gas field, signaling significant potential for future discoveries and development.

Eskan Company has received conditional approval for C$13.5 million in funding from Canada’s Critical Minerals Infrastructure Fund to advance the Trans-Atikh Project, a key infrastructure initiative supporting lithium development in Quebec’s Eeyou Istchee James Bay region.

Wellnex Life Limited has announced a non-renounceable entitlement offer to raise approximately $22.1 million at $0.65 per share, supporting its planned AIM listing and strategic growth initiatives.

Arovella Therapeutics has requested a voluntary suspension of its ASX-listed securities pending a material announcement on a capital raising, expected by 17 February 2025.

BTC Health has transformed its decade-long license agreement with Arna Pharma into an indefinite partnership, gaining royalties from Singapore and Malaysia sales and first rights to new pharmaceutical products in Australia and New Zealand.

Micro-X Limited's trading suspension has been lifted following its announcement of an equity raising, signaling renewed market activity for the medical technology firm.